Meta Pixel

News and Announcements

MBD Energy Ltd – CEO Interview

  • Published October 02, 2014 3:42PM UTC
  • Publisher Wholesale Investor
  • Categories Executive Interviews

MBD provides a cost effective solution to the clean-up of industrially contaminated waste-water while it produces a valuable algal biomass by-products that will generate significant secondary income streams. MBD is currently focused on the deployment of four projects:

Pacific Reef Fisheries — This project enables the MBD land-based aquaculture enterprise to attain the necessary regulatory approval to undertake significant expansion. MBD will be paid to clean the water and generate additional profit from the sale of high-value food and agricultural feed by-products by undertaking this project.

Astaxanthin Production — MBD has achieved world-leading productivity in the cultivation of Astaxanthin, a red dye used in the nutraceuticals and food industries, which has a current value exceeding $250 per kg on the global market.

China Joint Venture — MBD is developing a JV in China with Shandong Ocard for the clean-up of nutrient contaminated water throughout the Provence of Shandong. The joint venture will convert the resultant algal biomass into fertilizer and synthetic bio-crude.

Ratchaburi Power Station — A JV with Loxley Pc, Ratchaburi and Bangchak Petroleum in which MBD convert the harvested biomass into refinery-ready synthetic bio-crude.  This project is funded by the JV partners and the Thai Government.

Capital Insights
What is a Wholesale Investor in Australia? Complete 2026 Guide

What is a Wholesale Investor in Australia? A wholesale investor is an individual or entity that meets specific financial thresholds set out in the Corporations Act 2001 (Cth), qualifying them to access investment opportunities that are not available to general retail investors. These include private equity rounds, venture capital deals, pre-IPO placements, alternative funds, and […]

Capital Insights
Why the 20-Year Hold Is the Secret to Australian Life Sciences Returns

Australia represents 0.3% of the world’s population. Yet it generates more than 3% of global research output. Cochlear implants. Wi-Fi. The HPV vaccine. These are not statistical anomalies. They are proof points of a structural advantage that Australia has failed to capitalise on. The country has a world-class research base. But it watches companies scale […]

Join over 45,000+ sophisticated investors

Join Now